biuro@scopefluidics.com
+48 22 376 21 14
About
Team
Our offer
Knowledge base
News
Investor relations
Career
Contact
biuro@scopefluidics.com
+48 22 376 21 14
About
Team
Our offer
Knowledge base
News
Investor relations
Career
Contact
biuro@scopefluidics.com
+48 22 376 21 14
Category
Uncategorized
31
Mar
Scope Fluidics begins certification clinical trials of SARS-CoV-2 panel adapted for scaled-up production
31.03.2022
db
Uncategorized
Read More
28
Apr
Scope Fluidics S.A. completes certification clinical trials for its SARS-CoV-2 panel and commences certification clinical trials for its MRSA/MSSA panel
28.04.2022
db
Uncategorized
Read More
11
Apr
Scope Fluidics extends the functionality of the BacterOMIC system diagnostic panel and begins its validation study
11.04.2022
db
Uncategorized
Read More
28
Oct
BacterOMIC system for identifying antibiotic resistance has obtained the European CE IVD marking approval
28.10.2021
Mateusz
Uncategorized
Read More
28
Jun
Scope Fluidics has completed the fourth stage of the PCR|ONE system – the panel for detecting Staphylococcus aureus is ready for testing in ALAB laboratoria
28.06.2019
Mateusz
Uncategorized
Read More
02
Jul
Scope Fluidics patents the key solution of the PCR|ONE system in the European Patent Office
02.07.2019
Mateusz
Uncategorized
Read More
07
Nov
The PCR|ONE system developed by Scope Fluidics achieves standard market parameters –the outcome of the second round of research in ALAB laboratories is now available
07.11.2019
Mateusz
Uncategorized
Read More
29
Nov
Scope Fluidics successfully tested the BacterOMIC system at the Microbiology Department of the National Tuberculosis and Lung Diseases Research Institute
29.11.2019
Mateusz
Uncategorized
Read More
29
Nov
Scope Fluidics has launched a manufacturing line for PCR system chips
29.11.2019
Mateusz
Uncategorized
Read More
25
Jul
Scope Fluidics obtains €1.93 million of Horizon 2020 funding for the BacterOMIC project
25.07.2019
Mateusz
Uncategorized
Read More
1
…
4
5
6
7
8
…
13
Search
Text Widget
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada magna mollis euismod.
Recent Comments
Tag Cloud
home
Recent Comments